Commit To Buy Impinj At $110, Earn 14.7% Annualized Using Options

The note evaluates selling a December $110 put on Impinj Inc (PI) as a trade that yields a 14.7% annualized return from the premium, while noting it only results in share ownership if PI falls ~30%. Current PI price cited is $157.81 and the calculated trailing-12-month volatility is 76%; if exercised the effective cost basis would be $96.00 per share (pre-commissions). The analysis emphasizes the limited upside for the put seller versus direct equity ownership and frames the decision as a risk/reward judgment combining price history, volatility and fundamentals.

Analysis

Market structure: The options market signals heavy demand for downside protection in PI — a 110-dec put that implies a $96 net buy price and a 14.7% annualized yield vs. trailing realized vol ~76% means sellers collect yield while taking large tail exposure (current PI $157.81; 110 strike ≈ -30%). Direct winners from aggressive put-selling are retail/hedge sellers collecting premium and market-makers; losers are equity holders if a 30%+ drawdown occurs and liquidity worsens. Cross-asset: a large unwind would pressure small-cap tech, widen credit spreads for small SaaS/hardware names, and lift treasury safe-haven flows for days-weeks.

Risk assessment: Tail risks include demand shock for RAIN RFID adoption, customer concentration, or a semiconductor cyclical draw (20–50% downside scenarios) and operational execution failures; regulatory/privacy rules could permanently reduce TAM. Immediate (days): theta favors sellers; short-term (weeks–3 months): earnings or supply-chain news could swing IV ±30–60 pts; long-term (quarters–years): secular adoption still intact but competitive pricing pressure may compress margins. Hidden dependency: option sellers are exposed to IV re-pricing (vol crush helps sellers, vol spike hurts), and counterparty/assignment clustering around expiration can force disorderly purchases.

Trade implications: If comfortable acquiring PI, consider a limited cash-secured put sell (Dec 110) sized 1–2% portfolio risking assignment at $96 net — only if willing to own at that level; prefer a 110/90 put spread to cap max loss to ~$10–$20 per share minus credit. Relative trade: short PI vs long SMH (VanEck SMH) to express company-specific cyclicality — short 0.5–1% vs long 1–2% SMH. If directional bullish but want lower theta risk, buy 12–24 month LEAP call (e.g., 2027 Jan) on dips below $120.

Contrarian angles: Consensus underestimates distribution risk — 14.7% annualized premium is thin versus 76% realized vol and potential >30% drawdown, so naked put selling is likely undercompensated for tail risk unless position sizes are tiny. Historical parallels: small-cap semiconductor/IoT names often gap 30–60% on single negative surprises; volatility skew favors selling premium but beware post-earnings vol spikes and assignment clustering. Unintended consequence: mass put-selling could concentrate ownership among assigned buyers, creating forced selling when liquidity tightens — avoid leverage and use defined-loss spreads.

Key Decisions for Investors

• Sell a limited cash-secured Dec 110 put on PI (current 157.81) sized 1% of portfolio if you are willing to own PI at $96 net; set a hard position cap and treat assignment as a buy-on-dip rather than a trade.
• Prefer the defined-risk alternative: sell PI Dec 110 / 90 put spread sized 2% max risk (max loss ≈ $10 wide − credit); collect premium but cap downside and avoid naked assignment tail risk.
• Establish a relative-value pair: short PI (0.5% portfolio) and go long SMH (1–2% portfolio) to isolate company-specific downside vs. broad semiconductor recovery; exit if PI > 165 or SMH underperforms by >8% in 4 weeks.
• Buy a protective 12–24 month LEAP call on PI (e.g., 2027 Jan) on any drop below $120, size 0.5–1% as a longer-term bullish/rehab play; alternatively avoid naked equity exposure if IV > 60th percentile and wait for IV compression >20% before initiating net short-premium strategies.